Association of hemoglobin levels in the first trimester and at 26 to 30 weeks with fetal and neonatal outcomes: A secondary analyses of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial

Association of hemoglobin levels in the first trimester and at 26 to 30 weeks with fetal and neonatal outcomes: A secondary analyses of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial

Both lower and some higher HGB concentrations were associated with adverse fetal and neonatal outcomes at 6 −13 weeks and at 26–30 weeks GA.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJOG : an international journal of obstetrics and gynaecology 2021-04, Vol.128 (9), p.1487-1496
Hauptverfasser: Jessani, Saleem, Saleem, Sarah, Hoffman, Matthew K., Goudar, Shivaprasad S., Derman, Richard J., Moore, Janet L., Garces, Ana, Figueroa, Lester, Krebs, Nancy F., Okitawutshu, Jean, Tshefu, Antoinette, Bose, Carl L., Mwenechanya, Musaku, Chomba, Elwyn, Carlo, Waldemar A., Das, Prabir Kumar, Patel, Archana, Hibberd, Patricia L., Esamai, Fabian, Liechty, Edward A., Bucher, Sherri, Nolen, Tracy L., Koso-Thomas, Marion, Miodovnik, Menachem, McClure, Elizabeth M., Goldenberg, Robert L.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Both lower and some higher HGB concentrations were associated with adverse fetal and neonatal outcomes at 6 −13 weeks and at 26–30 weeks GA.
ISSN:1470-0328
1471-0528
DOI:10.1111/1471-0528.16676